Guerbet

Guerbet: Appointment of Mr. François Convenant as Senior Vice President of Interventional Radiology and his entry into the Executive Committee

19 Dec 2025 02:45:00 By Nasdaq GlobeNewswire

GUERBET : Adjustment of 2025 financial targets.

02 Dec 2025 11:45:00 By Nasdaq GlobeNewswire

GUERBET : Financial agenda for 2026

19 Nov 2025 07:47:34 By Nasdaq GlobeNewswire

Guerbet : Revenue at September 30, 2025. Return to growth in Q3 2025. Confirmation of all financial targets for 2025.

23 Oct 2025 11:45:00 By Nasdaq GlobeNewswire

Guerbet : H1 2025 results : H1 revenue: €387.8 million, down 5.4% at CER and on a like-for-like basis, mainly due to the decline in activity in France

24 Sep 2025 11:45:00 By Nasdaq GlobeNewswire

Guerbet : Change in General Management

22 Sep 2025 11:45:00 By Nasdaq GlobeNewswire

Guerbet : Adjustment of 2025 full-year financial targets

15 Sep 2025 11:50:00 By Nasdaq GlobeNewswire

Guerbet : H1 2025 revenue

24 Jul 2025 11:45:00 By Nasdaq GlobeNewswire

Guerbet : Changes in the composition of the Guerbet board of directors.

26 May 2025 02:42:52 By Nasdaq GlobeNewswire

Guerbet: Q1 2025 revenue

24 Apr 2025 11:45:00 By Nasdaq GlobeNewswire

GUERBET : 2024 full-year results.

26 Mar 2025 12:45:00 By Nasdaq GlobeNewswire

DUOncoTM Bone : First CE marked IA algorithm for automatic detection of bone lesions on CT scan.

18 Mar 2025 12:45:00 By Nasdaq GlobeNewswire

GUERBET : 2024 revenue.

06 Feb 2025 11:45:00 By Nasdaq GlobeNewswire

GUERBET : Implementation of a Liquidity Contract with NATIXIS ODDO BHF

03 Feb 2025 06:00:00 By Nasdaq GlobeNewswire

Correction: GUERBET : Financial agenda for 2025

31 Oct 2024 13:00:00 By Nasdaq GlobeNewswire

GUERBET : Revenue at September 30, 2024.

24 Oct 2024 11:45:00 By Nasdaq GlobeNewswire

GUERBET : H1 2024 results.

25 Sep 2024 11:45:00 By Nasdaq GlobeNewswire

GUERBET : H1 2024 revenue.

25 Jul 2024 11:45:00 By Nasdaq GlobeNewswire

Guerbet : Hugues Lecat appointed Chairman of the Board of Directors of Guerbet.

24 May 2024 11:44:58 By Nasdaq GlobeNewswire

Guerbet : NUCLIDIUM and Guerbet Form Strategic Partnership to Support the Advancement of targeted Copper-based Radiotheranostics.

22 May 2024 11:45:00 By Nasdaq GlobeNewswire